AcquisitionHealthcare & Life Sciences
Redcliffe Labs acquires Megavision Diagnostics for ₹40 Cr
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
- Redcliffe Labs is an omnichannel diagnostics platform offering over 3,600 tests across India
- It has acquired Pune-based Megavision Diagnostics Centre for ₹40 Cr ($4.14 Mn), expected to close in July 2026
- The deal follows two smaller acquisitions and a divestiture of its fertility business earlier this year
What happened
- Redcliffe Labs is acquiring Megavision Diagnostics Centre in a ₹40 Cr deal.
- Megavision is a Pune-based diagnostics chain founded in 1996 with two centres in Pimpri and Nigdi.
- It offers MRI, CT scans, sonography, ECG, and mammography services.
- Megavision's annual revenue is about ₹20 Cr.
- The transaction is expected to close later this month (July 2026).
- Redcliffe will retain Megavision's entire workforce.
- Weeks before this deal, Redcliffe acquired Prime Sonography and Diagnostic Center (Kota) for about ₹5 Cr and Sarvodaya Diagnostics (Ajmer) for about ₹10 Cr.
- Earlier in 2026, Redcliffe divested its fertility business Crysta IVF to Moon Care Pvt Ltd for about ₹100 Cr.
Why it matters
- Redcliffe's revenue grew 12% to ₹470 Cr in FY26 from ₹418 Cr in FY25.
- Its EBITDA loss margin narrowed to -13% in FY26 from -24% in FY25.
- The company targets revenue of about ₹700 Cr in FY27, nearly 50% growth.
- Redcliffe has raised $115 Mn to date from investors including LeapFrog Investments and HealthQuad.
The business
- Redcliffe Labs is an omnichannel diagnostics platform with over 3,600 pathology tests.
- It offers genetic and DNA-based screening for reproductive health, cancer, and wellness.
- The company operates in 70-80 cities across India.
- It has 80+ self-owned certified labs and 2,000+ collection centres.
- Home sample collection accounts for nearly half of its business.
- Redcliffe served more than 4.3 Mn customers in FY26, conducting 24 Mn diagnostic tests.
- 64% of its customer base comes from Tier I and II cities.
- It provides AI-enabled diagnostic reports, consultations, and diet plans through its mobile app.
The founders
- Cofounder and CEO of Redcliffe Labs.
DJ
Dheeraj Jain
Cofounder and Chairman- Cofounder and Chairman of Redcliffe Labs.
In numbers
₹40 CrDeal value · 2026
₹20 CrMegavision annual revenue
₹470 CrRedcliffe revenue · FY26
₹418 CrRedcliffe revenue · FY25
-13%Redcliffe EBITDA loss margin · FY26
-24%Redcliffe EBITDA loss margin · FY25
-80%Redcliffe EBITDA loss margin · FY23
40%Redcliffe CAGR
₹700 CrRedcliffe revenue target · FY27
4.3 MnCustomers served · FY26
24 MnDiagnostic tests conducted · FY26
$115 MnTotal funding raised
What happens next
- Redcliffe targets revenue of about ₹700 Cr in FY27, nearly 50% year-on-year growth.
Up against
HealthiansThyrocareDr Lal PathLabsSRL DiagnosticsApollo Diagnostics
Words to know
- EBITDA
- Earnings Before Interest, Taxes, Depreciation, and Amortisation – a measure of a company's operating profitability.
- Omnichannel
- A business model that integrates online and offline channels to provide a seamless customer experience.
- Phlebotomist
- A trained professional who draws blood from patients for medical testing.
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 17 September 2024 | Series C | $42M | IFU (Denmark's Investment Fund for Developing Countries) |
| 13 August 2023 | growth | $80 million | |
| 29 September 2022 | Series B | $100-125 million | |
| 6 May 2022 | Series B | $61M | LeapFrog Investments |
Healthcare & Life Sciences in July 2026: 11 rounds with a disclosed amount, $87.1 million in all; the biggest was Iswarya (Rs 350 crore). Every sector this year →
Other articles talking about it
Terms in this story
- Mergers and acquisitions: An acquisition is when one company buys another, and a merger is when two companies combine into one. For most Indian startups a sale is a likelier exit than an IPO, and the Competition Commission of India (CCI) must approve deals that cross its asset, turnover or ₹2,000 crore deal-value limits.
Read next
FundingRedcliffe Lifetech raises $61 million Series BRedcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic testsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Redcliffe Labs → · All startup news on 20 July 2026 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →